Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Definitive HealthcareDH -4.96%49 EV-to-OCF is 2.77 as of Aug. 02, 2026, which is 91% below its 10-year median of 31.57. GuruFocus rates DH with a GF Score™ of 49/100 and a GF Value™ of $4.41 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 683 Healthcare Providers & Services companies, Definitive Healthcare ranks better than 67.94% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Definitive Healthcare's Enterprise Value is $108.7 Mil.
Definitive Healthcare's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 was $39.3 Mil. Therefore, Definitive Healthcare's EV-to-OCF for today is 2.77.
The historical rank and industry rank for Definitive Healthcare's EV-to-OCF or its related term are showing as below:
DH'
s EV-to-OCF Range Over the Past 10 Years
Min: 2.68 Med: 31.57 Max: 157.48
Current: 2.77
During the past 7 years, the highest EV-to-OCF of Definitive Healthcare was 157.48. The lowest was 2.68. And the median was 31.57.
DH's EV-to-OCF is ranked better than 67.94% of 683
companies
in the Healthcare Providers & Services industry
Industry Median: 8.64
vs DH: 2.77
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Definitive Healthcare's PE Ratio (TTM) for today is calculated as:
Definitive Healthcare's share price for today is $0.6865.
Definitive Healthcare's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.620.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Definitive Healthcare's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Definitive Healthcare EV-to-OCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Definitive Healthcare's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Definitive Healthcare's EV-to-OCF falls into.
Definitive Healthcare's current Enterprise Value is $108.7 Mil.
Definitive Healthcare's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $39.3 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Definitive Healthcare (DH) has a EV-to-OCF of 2.77 as of Aug. 02, 2026. This is 91% below median its historical median of 31.57. Over the past decade, Definitive Healthcare's EV-to-OCF has ranged from 2.68 to 157.48. According to the industry distribution chart, Definitive Healthcare ranks #219 out of 683 companies in the Healthcare Providers & Services industry, placing it in the top 32.1%.
Is Definitive Healthcare's EV-to-OCF too high?
Definitive Healthcare's current EV-to-OCF of 2.77 is 91% below median its 10-year median of 31.57. Over the past 10 years, this metric has ranged from a low of 2.68 to a high of 157.48. The Healthcare Providers & Services industry median EV-to-OCF is 8.64. Definitive Healthcare's value of 2.77 is 67.9% below this industry median. Based on the distribution chart, Definitive Healthcare ranks #219 out of 683 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Definitive Healthcare has a GF Score™ of 49/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Definitive Healthcare's EV-to-OCF compare to DRIO and CCLD?
According to the Healthcare Providers & Services industry distribution chart, Definitive Healthcare ranks #219 out of 683 companies for EV-to-OCF. This puts Definitive Healthcare in the upper half of its industry. The industry median EV-to-OCF is 8.64. Definitive Healthcare's value of 2.77 is 67.9% below this benchmark. Historically, Definitive Healthcare's own EV-to-OCF has ranged from 2.68 to 157.48 over the past decade. While the company's 10-year median is 31.57 vs. the industry median of 8.64, Definitive Healthcare has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Healthcare Providers & Services company?
The median EV-to-OCF among Healthcare Providers & Services companies is 8.64, based on 683 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Definitive Healthcare's current EV-to-OCF of 2.77 is 67.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median EV-to-OCF is 8.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Definitive Healthcare's current EV-to-OCF is 2.77, which is 91% below median its own 10-year median of 31.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Definitive Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Definitive Healthcare (DH) is currently considered Possible Value Trap. The stock's GF Value™ is $4.41, compared to a current price of $0.69 — trading 84.4% below its estimated fair value. The current EV-to-OCF is 2.77, which is 91% below median its 10-year median of 31.57 and 67.9% below the Healthcare Providers & Services industry median of 8.64. Definitive Healthcare's overall GF Score™ is 49/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Definitive Healthcare (DH), the current EV-to-OCF is 2.77 as of Aug. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Definitive Healthcare (DH) Overvalued in 2026?
Based on GuruFocus' analysis, Definitive Healthcare stock appears to be undervalued.
The current stock price of $0.69 is trading 84.4% below its estimated GF Value™ of $4.41.
GuruFocus considers Definitive Healthcare to be Possible Value Trap.
Key valuation signals for DH:
EV-to-OCF: 2.77 (91% below median its 10-year median of 31.57)
GF Value™: $4.41 vs. price of $0.69 (84.4% below fair value)
Industry Position: 67.9% below the Healthcare Providers & Services median (#219 of 683)
No single metric tells the full story. See the DH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Definitive Healthcare Corp is a provider of healthcare commercial intelligence. Its SaaS-based healthcare commercial intelligence platform is designed to provide comprehensive and accurate information on the healthcare ecosystem in the U.S. The platform uses deep analytics and data science to help customers develop data-driven strategic decisions, such as finding new markets to enter, building comprehensive go-to-market strategies, accessing tactical information to help target the right decision makers, and improving win rates with detailed contextual information. The company derives substantially all of its revenue from the sale of subscription fees for access to its platform and stand-ready support. Geographically, it derives a majority of its revenue from the United States.
49GF Score
Get the complete analysis for DH
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DH has been successfully added to your 
